Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 03 2020
accepted: 02 10 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 15 12 2020
Statut: epublish

Résumé

Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute heart failure during the peripartum period. It is common in patients of African ancestry. Currently, there is paucity of data on the burden, predictors and outcomes of PPCM in Uganda. This study aimed to investigate the prevalence, predictors and six-month outcomes of PPCM in an adult cohort attending a tertiary specialised cardiology centre in Kampala, Uganda. This study consecutively enrolled 236 women presenting with features of acute heart failure in the peripartum period. Clinical evaluation and echocardiography were performed on all the enrolled women. PCCM was defined according to recommendations of the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Poor outcome at six months of follow-up was defined as presence of any of the following: death of a mother or her baby, New York Heart Association (NYHA) functional class III-IV or failure to achieve complete recovery of left ventricular function (left ventricular ejection fraction ≤55%). The median age, BMI and parity of the study participants was 31.5 (25.5-38.0) years, 28.3 (26.4-29.7) and 3 (2-4) respectively. The prevalence of PPCM was 17.4% (n = 41/236). Multiple pregnancy was the only predictor of PPCM in this study population (OR 4.3 95% CI 1.16-16.05, p = 0.029). Poor outcome at six-months was observed in about 54% of the patients with PPCM (n = 4, 9.8% in NYHA functional class III-IV and n = 22, 53.7% with LVEF <55%). No maternal or foetal mortality was documented. PPCM is relatively common in Uganda and is associated with multiple pregnancy. Poor outcomes especially absence of complete recovery of left ventricular function are also common. Large studies to further investigate long-term maternal and foetal outcomes in Uganda are justified.

Sections du résumé

BACKGROUND
Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute heart failure during the peripartum period. It is common in patients of African ancestry. Currently, there is paucity of data on the burden, predictors and outcomes of PPCM in Uganda. This study aimed to investigate the prevalence, predictors and six-month outcomes of PPCM in an adult cohort attending a tertiary specialised cardiology centre in Kampala, Uganda.
METHODS
This study consecutively enrolled 236 women presenting with features of acute heart failure in the peripartum period. Clinical evaluation and echocardiography were performed on all the enrolled women. PCCM was defined according to recommendations of the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Poor outcome at six months of follow-up was defined as presence of any of the following: death of a mother or her baby, New York Heart Association (NYHA) functional class III-IV or failure to achieve complete recovery of left ventricular function (left ventricular ejection fraction ≤55%).
RESULTS
The median age, BMI and parity of the study participants was 31.5 (25.5-38.0) years, 28.3 (26.4-29.7) and 3 (2-4) respectively. The prevalence of PPCM was 17.4% (n = 41/236). Multiple pregnancy was the only predictor of PPCM in this study population (OR 4.3 95% CI 1.16-16.05, p = 0.029). Poor outcome at six-months was observed in about 54% of the patients with PPCM (n = 4, 9.8% in NYHA functional class III-IV and n = 22, 53.7% with LVEF <55%). No maternal or foetal mortality was documented.
CONCLUSION
PPCM is relatively common in Uganda and is associated with multiple pregnancy. Poor outcomes especially absence of complete recovery of left ventricular function are also common. Large studies to further investigate long-term maternal and foetal outcomes in Uganda are justified.

Identifiants

pubmed: 33085703
doi: 10.1371/journal.pone.0240837
pii: PONE-D-20-07456
pmc: PMC7577461
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0240837

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010132
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bull World Health Organ. 1974;51(2):203-8
pubmed: 4549486
Heart. 2013 Mar;99(5):308-13
pubmed: 23118348
Int J Cardiol. 2012 May 17;157(1):e12-3
pubmed: 21962610
PLoS One. 2018 Dec 26;13(12):e0208931
pubmed: 30586432
Int J Cardiol. 2015;190:376-82
pubmed: 25966297
Int J Cardiol. 2011 Mar 3;147(2):342-3
pubmed: 21247640
Cardiovasc J Afr. 2016 Mar-Apr;27(2):66-70
pubmed: 27213852
Indian Heart J. 2006 May-Jun;58(3):234-8
pubmed: 19033622
Heart. 2014 Dec;100(24):1967-74
pubmed: 25227705
Nat Rev Cardiol. 2014 Jun;11(6):364-70
pubmed: 24686946
Ethn Dis. 2007 Spring;17(2):228-33
pubmed: 17682350
Nature. 2012 May 09;485(7398):333-8
pubmed: 22596155
Cardiovasc J Afr. 2017 Jan/Feb;28(1):8-13
pubmed: 28262909
J Am Coll Cardiol. 2011 Aug 9;58(7):659-70
pubmed: 21816300
ESC Heart Fail. 2020 Feb;7(1):235-243
pubmed: 31990449
N Engl J Med. 2015 Aug 6;373(6):540-7
pubmed: 26244307
Am J Cardiol. 2007 Jul 15;100(2):302-4
pubmed: 17631087
Cardiovasc J Afr. 2017 Mar/Apr 23;28(2):112-117
pubmed: 27701482
J Am Coll Cardiol. 2010 Feb 16;55(7):654-9
pubmed: 20170791
Eur J Heart Fail. 2019 Jul;21(7):827-843
pubmed: 31243866
Heart Views. 2016 Apr-Jun;17(2):55-61
pubmed: 27512533
BMC Cardiovasc Disord. 2016 Jan 29;16:27
pubmed: 26821537
BMC Cardiovasc Disord. 2018 Jun 18;18(1):119
pubmed: 29914408
BMC Cardiovasc Disord. 2008 Jul 22;8:16
pubmed: 18644161
Int J Mol Sci. 2015 Apr 07;16(4):7644-54
pubmed: 25853263
Trop Doct. 1995 Jul;25(3):118-23
pubmed: 7660481
J Am Coll Cardiol. 2013 Oct 29;62(18):1715-1723
pubmed: 24013055
PLoS One. 2015 Aug 07;10(8):e0133466
pubmed: 26252951
Int J Cardiol. 2011 Mar 3;147(2):202-8
pubmed: 19751951
Eur J Heart Fail. 2017 Dec;19(12):1723-1728
pubmed: 28345302
Eur J Heart Fail. 2017 Sep;19(9):1131-1141
pubmed: 28271625

Auteurs

Juliet Nabbaale (J)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

Emmy Okello (E)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

Davis Kibirige (D)

Department of Medicine, Uganda Martyrs Hospital Lubaga, Kampala, Uganda.

Isaac Ssekitoleko (I)

Statistics Unit, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.

Joseph Isanga (J)

Department of Obstetrics and Gynaecology, Case Hospital, Kampala, Uganda.

Patience Karungi (P)

Graduate Entry Medical School, University of Limerick, Limerick, Ireland.

Elias Sebatta (E)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

Zhang Wan Zhu (ZW)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

Annettee Nakimuli (A)

Department of Obstetrics and Gynaecology, School of Medicine-Makerere University College of Health Sciences, Kampala, Uganda.

John Omagino (J)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

James Kayima (J)

Division of Adult Cardiology, Uganda Heart Institute, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH